• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过荧光原位杂交检测到的膀胱癌基因组异质性。

Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.

作者信息

Yokogi H, Wada Y, Moriyama-Gonda N, Igawa M, Ishibe T

机构信息

Department of Urology, Shimane Medical University, Izumo, Japan.

出版信息

Br J Urol. 1996 Nov;78(5):699-703. doi: 10.1046/j.1464-410x.1996.01786.x.

DOI:10.1046/j.1464-410x.1996.01786.x
PMID:8976763
Abstract

OBJECTIVE

To investigate the relationship between genomic heterogeneity and tumour grade, stage and DNA content in 30 transitional cell carcinomas (TCCs) of the urinary bladder.

MATERIALS AND METHODS

Tissue specimens from 30 patients (25 men and five women) with newly diagnosed TCC of the urinary bladder were examined for genomic heterogeneity using fluorescence in situ hybridization (FISH) with chromosome-specific DNA probes; the copy number of pericentromeric sequences on chromosomes 7, 9 and 17 was detected within interphase nuclei in contact preparations from the tumour specimens.

RESULTS

The aneusomy of chromosomes 7, 9 and 17 was significantly higher in aneuploid than in diploid tumours (P < 0.001). Tumour grade and stage were strongly associated with aneusomy for chromosome 17 (P < 0.01, P < 0.001, respectively). The aneusomy of chromosomes 7 and 9 were significantly correlated with increasing tumour stage (P < 0.001), but not with tumour grade.

CONCLUSION

These results suggest that the measurement of aneusomy using FISH, especially for chromosome 17, in bladder cancer may offer a new objective and quantitative assay of the biological potential of individual tumours.

摘要

目的

研究30例膀胱移行细胞癌(TCC)的基因组异质性与肿瘤分级、分期及DNA含量之间的关系。

材料与方法

采用染色体特异性DNA探针的荧光原位杂交(FISH)技术,对30例新诊断为膀胱TCC的患者(25例男性和5例女性)的组织标本进行基因组异质性检测;在肿瘤标本的接触制片的间期核内检测7号、9号和17号染色体着丝粒周围序列的拷贝数。

结果

非整倍体肿瘤中7号、9号和17号染色体的非整倍体率显著高于二倍体肿瘤(P < 0.001)。肿瘤分级和分期与17号染色体的非整倍体密切相关(分别为P < 0.01,P < 0.001)。7号和9号染色体的非整倍体与肿瘤分期增加显著相关(P < 0.001),但与肿瘤分级无关。

结论

这些结果表明,利用FISH检测非整倍体,尤其是17号染色体,可能为膀胱癌个体肿瘤的生物学潜能提供一种新的客观定量检测方法。

相似文献

1
Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.通过荧光原位杂交检测到的膀胱癌基因组异质性。
Br J Urol. 1996 Nov;78(5):699-703. doi: 10.1046/j.1464-410x.1996.01786.x.
2
Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder.染色体7和17的非整倍体可预测膀胱移行细胞癌的复发。
BJU Int. 2000 Jan;85(1):42-7. doi: 10.1046/j.1464-410x.2000.00326.x.
3
Interphase cytogenetics of bladder cancer progression: relationship between aneusomy, DNA ploidy pattern, histopathology, and clinical outcome.
Int J Clin Lab Res. 2000;30(1):5-11. doi: 10.1007/s005990070026.
4
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?9号染色体缺失是膀胱移行细胞癌疾病复发的标志物吗?
Br J Cancer. 1998 Jun;77(12):2193-8. doi: 10.1038/bjc.1998.365.
5
[Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].[应用多色荧光原位杂交技术检测膀胱尿路上皮癌]
Ai Zheng. 2007 Feb;26(2):189-93.
6
Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer.在人类膀胱癌中,7号染色体着丝粒拷贝数与肿瘤分级和标记指数密切相关。
Cancer Res. 1991 Jul 15;51(14):3807-13.
7
Numerical chromosome aberrations in bladder cancer detected by in situ hybridization.通过原位杂交检测膀胱癌中的染色体数目畸变。
Br J Urol. 1995 Apr;75(4):470-6. doi: 10.1111/j.1464-410x.1995.tb07267.x.
8
Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma.膀胱移行细胞癌冲洗液和活检材料中8号和11号染色体非整倍体的评估。
Cancer Genet Cytogenet. 2003 Apr 1;142(1):25-9. doi: 10.1016/s0165-4608(02)00803-8.
9
Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.膀胱移行细胞癌中通过荧光原位杂交检测9号染色体畸变
Eur J Cancer. 2001 Aug;37(12):1496-503. doi: 10.1016/s0959-8049(01)00151-4.
10
Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.移行细胞癌中的染色体畸变:其与肿瘤行为的相关性。
Urol Int. 2002;69(2):129-35. doi: 10.1159/000065562.

引用本文的文献

1
One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection.对一种实验室研发的用于膀胱癌检测的寡核苷酸荧光原位杂交探针组检测方法进行为期一年的监测。
Res Rep Urol. 2015 Apr 9;7:49-55. doi: 10.2147/RRU.S79085. eCollection 2015.
2
Bladder tumor markers: from hematuria to molecular diagnostics--where do we stand?膀胱肿瘤标志物:从血尿到分子诊断——我们目前的状况如何?
Expert Rev Anticancer Ther. 2008 Jul;8(7):1111-23. doi: 10.1586/14737140.8.7.1111.
3
Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma.
荧光原位杂交检测的肾细胞癌染色体畸变与临床参数、DNA倍体及Ki 67表达的比较
Br J Cancer. 1998 Jun;77(11):2003-7. doi: 10.1038/bjc.1998.332.